In the coming years, Verb Surgical aims to develop a comprehensive surgical solutions platform that will incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals. The goal of Verb Surgical is to develop these new technologies in partnership with surgeons and hospitals to enable better patient outcomes, improve access to minimally invasive surgery, and achieve greater hospital efficiency.
Verb Surgical is supported by investments from Ethicon, Johnson & Johnson Innovation – JJDC, Inc., and Verily. Both Ethicon and Verily have contributed intellectual property, in-process R&D assets, and other resources to Verb Surgical, including managerial, technological, and surgical expertise. Verb Surgical will be headquartered in Mountain View, California. Under Mr. Huennekens’ leadership, the company will be overseen by a Board of Directors, which will include members from Ethicon, Johnson & Johnson Innovation, LLC , Verily and Google.
“I’m very excited about the possibilities that we can realize through our new surgical solutions company,” said Scott Huennekens, President & CEO, Verb Surgical. “By maximizing the distinct capabilities of these two market-leading companies, we aim to develop novel technologies and solutions to help improve the standard of care around the world. Our name speaks for itself. We are a company dedicated to action and to making a difference in people’s lives, in partnership with surgeons globally.”
Additional details regarding Verb Surgical Inc. and the development of its technologies will be communicated in the future by Verb Surgical.